Results 241 to 250 of about 156,135 (285)

Marginal Orbicularis Oris Hyperactivity (MOOH): An Exploratory Case Series of Inversion-Dominant Upper Lip Dynamics Following Intraoral Botulinum Toxin Type A. [PDF]

Toxins (Basel)
Armenti AF.
europepmc   +1 more source

Cell Membrane-Coated Nanoparticles: Advanced Drug Delivery Systems for Chronic Wound Healing Therapy. [PDF]

Int J Nanomedicine
Zhao X, Liu Q, Xu Z, Yang F, Li Z, Bai X, Zhu H, Liu Y, Wang Y.   +8 more
europepmc   +1 more source

<i>Clostridioides difficile</i> infection in pediatric inflammatory bowel disease: current understanding and clinical challenges. [PDF]

Front Pediatr
Rogalidou M.
europepmc   +1 more source

Botulinum Toxin Treatment Can Enlarge Eye Appearance in Asian Patients and Improves Social and Emotional Attributes. [PDF]

Toxins (Basel)
de Maio M, Kato K, Sato M, Horiuchi Y, Toyama T, Imaizumi A, Ishii H.   +6 more
europepmc   +1 more source

Sepsis and the diverse organ-gastrointestinal tract axis. [PDF]

World J Crit Care Med
Wang JDJ, Suan E, Li SS, Shelat VG.
europepmc   +1 more source

Bacteriophages as Antibacterial Agents Against Bovine Pathobionts Associated with Foodborne Human Morbidity. [PDF]

Viruses
Garvey M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical trials of targeted toxins

Seminars in Cancer Biology, 1995
Immunotoxins (monoclonal antibodies chemically coupled to peptide toxins) and fusion toxins (peptide ligands fused genetically to peptide toxins) have been used to treat a variety of malignancies over the last 20 years. Problems with normal tissue toxicities (vascular leak syndrome, hepatotoxicity, and neurotoxicities), poor penetration to tumor ...
Edward Tagge
exaly   +3 more sources

Targeting Bacterial Toxins

Angewandte Chemie International Edition, 2012
AbstractProtein toxins constitute the main virulence factors of several species of bacteria and have proven to be attractive targets for drug development. Lead candidates that target bacterial toxins range from small molecules to polymeric binders, and act at each of the multiple steps in the process of toxin‐mediated pathogenicity.
Mattias E, Ivarsson, Jean-Christophe, Leroux, Bastien, Castagner   +2 more
openaire   +4 more sources